Priya U Kumthekar

Associate Professor, Neurology
Associate Professor, Medicine, Hematology Oncology Division

Emailp-kumthekar@northwestern.edu

Source: Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

My interests include treating primary brain tumors such as gliomas and meningiomas. I also have a specific interest in metastatic disease to the brain from systemic cancers such as melanoma, lung and breast cancer and lead multiple trials in both primary brain tumors and metastatic disease. I am interested in providing novel care to my patients while maintaining quality of life.

Certifications and Licenses

Neurology

Training Experience

2008	Internship, Evanston Hospital
2011	Residency, Northwestern University, McGaw Medical Center
2012	Fellowship, Northwestern University, McGaw Medical Center

Education/Academic qualification

MD, Northeastern Ohio University

… → 2007

Research interests

Brain Cancer / Nervous System Cancer
Neuro-Oncology
Neurology

Fingerprint

Dive into the research topics where Priya U Kumthekar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

10 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

14 Finished
17 Active

Prot #XPORT-GBM-029: A Phase 1/2 Study of Selinexor in Combination with Standard of Care (SoC) Therapy for Newly Diagnosed or Recurrent Glioblastoma
Kumthekar, P. U.
ICON Clinical Research, LLC, Karyopharm Therapeutics Inc.
11/3/20 → 11/3/23
Project: Research project
Prot #AG881-C-004: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of AG-881 in Subjects With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation
Kumthekar, P. U.
DrugDev Inc., Agios Pharmaceuticals, Inc.
7/1/20 → 7/1/23
Project: Research project
North American Star Consortium
Kumthekar, P. U., Mahalingam, D., Sosman, J. A. & VanderWeele, D. J.
University Health Network (Toronto), National Cancer Institute
3/1/20 → 2/28/26
Project: Research project
Prot #NU 19C01: Understanding the Patient and Clinician Characteristics that Influence the Decision of Accepting Tumor Treating Fields (TTF) Therapy
Kumthekar, P. U.
Novocure Inc.
2/4/20 → 2/4/23
Project: Research project
DRUG M16-534 - Study Evaluating Ocular Side Effects of Depatux-M (ABT-414)
Kumthekar, P. U.
AbbVie Inc.
5/14/19 → 5/14/22
Project: Research project

717 Citations
31 Article
9 Review article
3 Chapter
1 Comment/debate
More
- 1 Editorial
- 1 Letter

ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
Kumthekar, P., Tang, S. C., Brenner, A. J., Kesari, S., Piccioni, D. E., Anders, C., Carrillo, J., Chalasani, P., Kabos, P., Puhalla, S., Tkaczuk, K., Garcia, A. A., Ahluwalia, M. S., Wefel, J. S., Lakhani, N. & Ibrahim, N., Jun 15 2020, In: Clinical Cancer Research. 26, 12, p. 2789-2799 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
22 Scopus citations
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
Cloughesy, T. F., Brenner, A., De Groot, J. F., Butowski, N. A., Zach, L., Campian, J. L., Ellingson, B. M., Freedman, L. S., Cohen, Y. C., Lowenton-Spier, N., Rachmilewitz Minei, T., Fain Shmueli, S., Avgeropoulos, N., Beck, J., Benkers, T., Bokstein, F., Brenner, A., Burton, E., Butowski, N., Campian, J. & 41 others, Carrillo, J., Cloughesy, T., De Groot, J., De Robles, P., Drappatz, J., Dunbar, I., Fink, K., Groves, M., Han, X., Adila, H., Jensen, R., Kowalska, A., Kumthekar, P., Lee, M., Lesser, G., Lossos, A., Lukas, R., Macdonald, D., Mammoser, A., Mechtler, L., Mohile, N., Nagpal, S., Nicholas, G., Kreisl, T., Pan, E., Peak, S., Pearlman, M., Perry, J., Peterson, R., Piccioni, D., Robins, H., Ronan, L., Salacz, M., Schiff, D., Tran, D., Zach, L., Tzuk-Shina, T., Walbert, T., Wen, P., Youst, S. & Wen, P. Y., May 15 2020, In: Neuro-oncology. 22, 5, p. 705-717 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
14 Scopus citations
Central nervous system cancers, version 3.2020
Nabors, L. B., Portnow, J., Ahluwalia, M., Baehring, J., Brem, H., Brem, S., Butowski, N., Campian, J. L., Clark, S. W., Fabiano, A. J., Forsyth, P., Hattangadi-Gluth, J., Holdhoff, M., Horbinski, C., Junck, L., Kaley, T., Kumthekar, P., Loeffler, J. S., Mrugala, M. M., Nagpal, S. & 15 others, Pandey, M., Parney, I., Peters, K., Puduvalli, V. K., Robins, I., Rockhill, J., Rusthoven, C., Shonka, N., Shrieve, D. C., Swinnen, L. J., Weiss, S., Wen, P. Y., Willmarth, N. E., Bergman, M. A. & Darlow, S. D., Nov 2020, In: JNCCN Journal of the National Comprehensive Cancer Network. 18, 11, p. 1537-1570 34 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
2 Scopus citations
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer
Malani, R., Fleisher, M., Kumthekar, P., Lin, X., Omuro, A., Groves, M. D., Lin, N. U., Melisko, M., Lassman, A. B., Jeyapalan, S., Seidman, A., Skakodub, A., Boire, A., DeAngelis, L. M., Rosenblum, M., Raizer, J. & Pentsova, E., Jul 1 2020, In: Journal of Neuro-Oncology. 148, 3, p. 599-606 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Scopus citations
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas
Drumm, M. R., Dixit, K. S., Grimm, S., Kumthekar, P., Lukas, R. V., Raizer, J. J., Stupp, R., Chheda, M. G., Kam, K. L., McCord, M., Sachdev, S., Kruser, T., Steffens, A., Javier, R., McCortney, K. & Horbinski, C., Apr 15 2020, In: Neuro-oncology. 22, 4, p. 470-479 10 p.
Research output: Contribution to journal › Article › peer-review
6 Scopus citations